M&T Bank Corp Acquires 19,500 Shares of DaVita Inc. $DVA

Key Points

• M&T Bank Corp increased its stake in DaVita by 694.7% in Q4, buying an additional 19,500 shares to hold 22,307 shares valued at about $2.534 million.
• DaVita beat quarterly expectations with $3.40 EPS vs. $3.24 and revenue of $3.62 billion vs. $3.51 billion, and set FY2026 guidance of 13.60–15.00 EPS (analysts average 14.16).
• Analysts' consensus is a "Hold" with an average price target of $155.80 (one Buy from UBS with a $190 PT), while the stock trades near $150.21 with a market cap of about $10.03 billion and a P/E of 15.16.

M&T Bank Corp lifted its position in shares of DaVita Inc. (NYSE:DVA - Free Report) by 694.7% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 22,307 shares of the company's stock after buying an additional 19,500 shares during the quarter. M&T Bank Corp's holdings in DaVita were worth $2,534,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the company. NewEdge Advisors LLC lifted its stake in shares of DaVita by 20.8% during the 1st quarter. NewEdge Advisors LLC now owns 511 shares of the company's stock valued at $78,000 after buying an additional 88 shares in the last quarter. Smartleaf Asset Management LLC lifted its stake in shares of DaVita by 34.9% during the 3rd quarter. Smartleaf Asset Management LLC now owns 452 shares of the company's stock valued at $59,000 after buying an additional 117 shares in the last quarter. Bank of Nova Scotia lifted its stake in shares of DaVita by 2.5% during the 3rd quarter. Bank of Nova Scotia now owns 4,933 shares of the company's stock valued at $655,000 after buying an additional 120 shares in the last quarter. TD Private Client Wealth LLC lifted its stake in shares of DaVita by 30.9% during the 3rd quarter. TD Private Client Wealth LLC now owns 564 shares of the company's stock valued at $75,000 after buying an additional 133 shares in the last quarter. Finally, Daiwa Securities Group Inc. lifted its stake in shares of DaVita by 2.2% during the 2nd quarter. Daiwa Securities Group Inc. now owns 6,502 shares of the company's stock valued at $926,000 after buying an additional 138 shares in the last quarter. Hedge funds and other institutional investors own 90.12% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on DVA. Weiss Ratings restated a "hold (c)" rating on shares of DaVita in a research note on Monday, December 29th. TD Cowen restated a "hold" rating on shares of DaVita in a research note on Tuesday, February 3rd. UBS Group boosted their price target on shares of DaVita from $186.00 to $190.00 and gave the stock a "buy" rating in a research note on Wednesday, February 4th. Barclays boosted their price target on shares of DaVita from $143.00 to $158.00 and gave the stock an "equal weight" rating in a research note on Tuesday, February 3rd. Finally, Truist Financial set a $158.00 price target on shares of DaVita in a research note on Thursday, February 5th. One equities research analyst has rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of "Hold" and an average price target of $155.80.

DaVita Trading Down 1.1%

Shares of NYSE DVA opened at $150.21 on Tuesday. The firm's 50-day moving average price is $150.94 and its 200-day moving average price is $130.93. The stock has a market capitalization of $10.03 billion, a price-to-earnings ratio of 15.16, a P/E/G ratio of 0.53 and a beta of 0.92. DaVita Inc. has a 12-month low of $101.00 and a 12-month high of $159.42.

DaVita (NYSE:DVA - Get Free Report) last announced its earnings results on Monday, February 2nd. The company reported $3.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.24 by $0.16. The firm had revenue of $3.62 billion for the quarter, compared to analysts' expectations of $3.51 billion. DaVita had a net margin of 5.47% and a negative return on equity of 413.18%. The business's revenue was up 9.9% compared to the same quarter last year. During the same period in the prior year, the company earned $2.24 EPS. DaVita has set its FY 2026 guidance at 13.600-15.00 EPS. On average, equities analysts predict that DaVita Inc. will post 14.16 EPS for the current fiscal year.

DaVita Profile

DaVita Inc NYSE: DVA is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.